Monday, December 04, 2017 3:06:18 PM
So its all speculation at this point. If the last couple months have proven anything its that we still have a way to the finish line (FDA clearance), but it's in sight. PPS will not be affected by normal variables until we uplist to NASDAQ and commence sales. I estimate we may get close to $2 pre FDA submit if momentum continues in a strong positive pattern. If we sell in the same timeframe could sell for $6per share range. But what do I know. Down the road and when sales commence we should climb higher. In 15-20 years this stock could be hundreds of dollars per share. I think thats what most investors here are banking on.
Queue honeycomb to discuss OS and RS...
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM